How can standard risk multiple myeloma (MM) patients be cured?
Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian
What is the focus of lymphoma research in 2017?
Highlights from ASH 2016: whole-genome sequencing to identify genomic lesions in ALL
Venetoclax and the future of treatment of multiple myeloma